Press Releases Archives - Page 15 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%

Lupin Digital Health’s Lyfe Platform Receives Class C Medical Device License from CDSCO

Lupin Receives EIR from U.S. FDA for its Aurangabad Manufacturing Facility

Lupin Launches Mirabegron Extended-Release Tablets in the United States

U.S. FDA Completes Inspection of Lupin’s Dabhasa Facility with No Observations

Lupin Launches First Generic Version of Oracea® (Doxycycline Capsules) in the United States

Lupin Receives Approval from U.S. FDA for Valbenazine Capsules

Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer

Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules

Lupin Receives Approval from U.S. FDA for Eslicarbazepine Acetate Tablets

1 2 … 14 15 16 … 102 103

Search

Hit enter to search or ESC to close